y 27632 has been researched along with pd 0325901 in 5 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (pd 0325901) | Trials (pd 0325901) | Recent Studies (post-2010) (pd 0325901) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 299 | 7 | 256 |
| Protein | Taxonomy | y 27632 (IC50) | pd 0325901 (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.015 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.015 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.006 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.025 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Mus musculus (house mouse) | 0.0003 | |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.078 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.0285 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Cao, N; Cui, C; Liao, J; Liu, L; Liu, Z; Wang, J; Xiao, L; Xu, P; Yang, HT; Yu, L; Zhu, W | 1 |
| Hashimoto, Y; Nakada, A; Nakamura, T; Shigeno, K; Shimada, H | 1 |
| Anand, M; Bontovics, B; Chrenek, P; Fábián, R; Gócza, E; Lázár, B; Makarevich, AV; Maraghechi, P; Németh, K; Vašíček, J | 1 |
5 other study(ies) available for y 27632 and pd 0325901
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
In vitro differentiation of rat embryonic stem cells into functional cardiomyocytes.
Topics: Action Potentials; Amides; Animals; Benzamides; Calcium; Cell Differentiation; Culture Media, Serum-Free; Diphenylamine; Embryonic Stem Cells; Glycogen Synthase Kinase 3; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Phenotype; Pyridines; Pyrimidines; Rats; rho-Associated Kinases | 2011 |
Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.
Topics: Amides; Animals; Benzamides; Butyrates; Cell Culture Techniques; Cell Differentiation; Cell Hypoxia; Cell Line; Diphenylamine; DNA Methylation; Enzyme Inhibitors; Gene Silencing; Genes, myc; Humans; Induced Pluripotent Stem Cells; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice; Mice, SCID; Octamer Transcription Factor-3; Pyrazoles; Pyridines; Pyrimidines; Retroviridae; SOXB1 Transcription Factors; Thiocarbamates; Thiosemicarbazones; Transduction, Genetic; Transgenes | 2012 |
The effect of dual inhibition of Ras-MEK-ERK and GSK3β pathways on development of
Topics: Amides; Animals; Benzamides; Diphenylamine; Embryo Culture Techniques; Embryo, Mammalian; Embryonic Development; Enzyme Inhibitors; Female; Germ Layers; Glycogen Synthase Kinase 3 beta; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Pyrazoles; Pyridines; Pyrimidines; Rabbits; ras Proteins; Thiosemicarbazones | 2020 |